Fibrinogen. Proceedings/ Workshop on Fibrinogen. Vol. 3 Structural variants and interactions: Stockholm, Sweden, July 9–10, 1983

دانلود کتاب Fibrinogen. Proceedings/ Workshop on Fibrinogen. Vol. 3 Structural variants and interactions: Stockholm, Sweden, July 9–10, 1983

55000 تومان موجود

کتاب فیبرینوژن مجموعه مقالات/کارگاه آموزشی فیبرینوژن. جلد 3 انواع ساختاری و تعاملات: استکهلم، سوئد، 9-10 ژوئیه، 1983 نسخه زبان اصلی

دانلود کتاب فیبرینوژن مجموعه مقالات/کارگاه آموزشی فیبرینوژن. جلد 3 انواع ساختاری و تعاملات: استکهلم، سوئد، 9-10 ژوئیه، 1983 بعد از پرداخت مقدور خواهد بود
توضیحات کتاب در بخش جزئیات آمده است و می توانید موارد را مشاهده فرمایید


این کتاب نسخه اصلی می باشد و به زبان فارسی نیست.


امتیاز شما به این کتاب (حداقل 1 و حداکثر 5):

امتیاز کاربران به این کتاب:        تعداد رای دهنده ها: 5


توضیحاتی در مورد کتاب Fibrinogen. Proceedings/ Workshop on Fibrinogen. Vol. 3 Structural variants and interactions: Stockholm, Sweden, July 9–10, 1983

نام کتاب : Fibrinogen. Proceedings/ Workshop on Fibrinogen. Vol. 3 Structural variants and interactions: Stockholm, Sweden, July 9–10, 1983
ویرایش : Reprint 2019
عنوان ترجمه شده به فارسی : فیبرینوژن مجموعه مقالات/کارگاه آموزشی فیبرینوژن. جلد 3 انواع ساختاری و تعاملات: استکهلم، سوئد، 9-10 ژوئیه، 1983
سری :
ناشر : De Gruyter
سال نشر : 1986
تعداد صفحات : 432
ISBN (شابک) : 9783110855951 , 9783110098068
زبان کتاب : German
فرمت کتاب : pdf
حجم کتاب : 18 مگابایت



بعد از تکمیل فرایند پرداخت لینک دانلود کتاب ارائه خواهد شد. درصورت ثبت نام و ورود به حساب کاربری خود قادر خواهید بود لیست کتاب های خریداری شده را مشاهده فرمایید.


فهرست مطالب :


Preface\nContents\nI. A HISTORICAL NOTE\nTwo thousand years of fibrinogen research and evidence for fibrin being the first protein\nII. GENE ANALYSIS\nFibrinogen evolution - The structure and evolution of fibrinogen: The coiled coil region\nAbsence of gross defect of fibrinogen genes in one patient with congenital afibrinogenemia\nIII. FIBRINOGEN-FIBRIN CONVERSION\nFibrinogen to fibrin - an overview\nFibrin - specific monoclonal antibodies are elicited by immunization with a synthetic fibrin-like peptide\nEnhancement of fibrin polymerization by active site - inhibited thrombin\nPeptides released from human fibrinogen by thrombic enzymes\nThe analysis of fibrinopeptide release from S--carboxymethylated fibrinogen chains using high-performance liquid chromatography\nMoaification of the fibrin a-chain by dipeptidyl peptidase IV\nIV. FIBRINOGEN-FIBRIN INTERACTION\nAnalysis of composition of soluble fibrinogen/fibrin complexes by differential ultracentrifugation\nReversible interactions of fibrin and fibrinogen: an ultracentrifugation study\nV. NORMAL FIBRINOGEN VARIANTS\nEvidence that the amount of heparin precipitable fraction is influenced by fibrinogen quality\nThe location of a second in vivo phosphorylation site in the Aa-chain of human fibrinogen\nEvidence that the y chain population of human platelet fibrinogen lacks the y\' variant that is present in plasma fibrinogen\nDifferences and similarities between human adult and fetal fibrinogen fragments D1\nVI. ABNORMAL FIBRINOGEN VARIANTS\nFunctional defects in abnormal fibrinogens\nStudy of 10 cases of congenital dysfibrinogenemia: clinical and molecular biological aspects\nFibrinogens Sydney I and II, a kinetic study of (His16 )FPA cleavage and its effect on FPB cleavage\nFibrinogens London I - IV, Manchester, Sydney I and II. Cleavage of fibrinopeptides by thrombin and expression of their polymerisation abnormalities\nAspects of evaluation of fibrinogen Stony Brook - A defect resulting in failure to release fibrinopeptide A\nFibrinogen Tokyo II: An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules\nFibrinogen Milan II: A congenital dysfibrinogenemia with a defective clotting by thrombin, normal clotting by arvin, reptilase and prothrombin-staphy1ocoagulase complex, associated with thrombotic episodes\nPreliminary report concerning two new cases of congenital dysfibrinogenemia (Homburg II and Homburg III)\nThe effect of sodium citrate on fibrin polymerisation in patients with liver disease\nVII. FIBRINOGEN DEGRADATION PRODUCTS\nStudies of the proteolytic fragments of the C-terminal portion of the a-chain of human fibrinogen\nBiodistribution or human fibrinogen-derived peptides in rabbits\nStructure-function studies on a vasoactive pentapeptide derived from plasm in degradation of human fibrin(ogen)\nPurification and characteristics of a vasoactive peptide derived from elastase degradation of human fibrin(ogen)\nRelation of crosslinked to non crosslinked fibrin derivatives in tumor ascites compared to cirrhosis ascites\nVIII. INTERACTION WITH PLASMINOGEN AND ITS ACTIVATOR\nStudy of the interaction between plasminogen and fibrinogen degradation products using immunoenzymological assay\nFibrin and plasminogen structures involved in the tissue-type plasminogen activator catalyzed activation of plasminogen\nKinetics of the tissue-type plasminogen activatormediated activation of plasminogen. Influence of CNBr fibrin(ogen) fragment FCB-2 and different forms of plasminogen\nIX. INTERACTION WITH CELLS\nStructural characterization of the recognition site for platelet receptors on human fibrinogen\nBinding or fibrinogen to ADP-treated platelets: Importance of the Aα-chain\nInhibition of fibrinogen binding to activated platelets by oligoamines\nSpecific interaction between fibrinogen-fibrin and endothelial cells\nInfluence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells\nInteraction of fibrin with malignant melanoma cells in long term culture\nAUTHOR INDEX\nSUBJECT INDEX




پست ها تصادفی